{
    "Trade/Device Name(s)": [
        "Alere BinaxNOW Influenza A & B Card 2",
        "Alere Reader",
        "BinaxNOW Influenza A & B Card 2",
        "BinaxNOW Card 2",
        "Alere Influenza A & B 2",
        "BinaxNOW Flu Card 2/Reader",
        "Lateral Flow Reader",
        "Card Test Analyzer"
    ],
    "Submitter Information": "Alere Scarborough, Inc.",
    "510(k) Number": "K181853",
    "Predicate Device Reference 510(k) Number(s)": [
        "K173502"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PSZ"
    ],
    "Summary Letter Date": "July 10, 2018",
    "Summary Letter Received Date": "July 11, 2018",
    "Submission Date": "July 10, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.3328"
    ],
    "Regulation Name(s)": [
        "Influenza virus antigen detection test system"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A nucleoprotein antigen",
        "Influenza B nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Nasal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Alere Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow"
    ],
    "Methodologies": [
        "Qualitative antigen detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "Instrument",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Alere BinaxNOW Influenza A & B Card 2 immunochromatographic assay and Alere Reader for qualitative detection of influenza A and B antigens.",
    "Indications for Use Summary": "Qualitative detection of influenza A and B nucleoprotein antigens in nasopharyngeal and nasal swab specimens to aid in rapid differential diagnosis of influenza A and B infections; results interpreted by Alere Reader.",
    "fda_folder": "Microbiology"
}